Which drugs can treat cataracts?

What drugs can treat cataracts? This is a question of great concern to many cataract patients. Unfortunately, there is no specific drug for cataract treatment so far. Currently, eye drops such as Cataract, Carlin U, Focalin, Glutathione, Leukocysteine and Salprace are mainly used to treat patients who are in early stage or temporarily not suitable for surgery, but their exact efficacy has yet to be summarized and studied.

These eye drops are usually given 3-4 times daily, one drop each time. If the symptoms improve, the drops can be continued. The solution should be kept in a sealed place away from light. Glutathione and other aqueous solutions are unstable and their efficacy disappears when stored at room temperature for about two weeks, so patients must prepare them freshly according to the drug instructions when using them.

To treat cataract, the most important thing is to actively treat the primary lesion while applying drugs. Except for senile cataracts which are related to degenerative changes of the body, most of the remaining cataracts have specific causes. For example, for those with restricted radioactive cataract clouding, the early clouding is often discontinued at a certain stage without further development as long as it is removed from radioactive nodal contact; for hand and foot twitch cataract, adequate amounts of vitamin A, D and calcium are given; for senile cataract with diabetes, the maturity age of cataract is 10 years earlier than that of the normal population, thus controlling blood sugar is an indispensable necessary measure for diabetic cataract. Thus, it is obvious that the practice of treating eye medicine as a “panacea” and neglecting the treatment of primary disease is “picking up sesame seeds and losing watermelon”.

Although drugs for cataracts have been used since the 1950s, finding effective drugs for cataracts is an extremely complicated and arduous task because the causes of cataracts, especially senile cataracts, are not yet fully understood. One day, when the microscopic world of intraocular material is studied in depth and the history of cataracts is precisely understood, a brilliant future of cataract treatment will be in sight.